Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells

ISSN： 1973-9478

Source： Journal of Chemotherapy, Vol.25, Iss.3, 2013-06, pp. : 162-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2

By Kurgan Nigel Tsakiridis Evelyn Kouvelioti Rozalia Moore Jessy Klentrou Panagiota Tsiani Evangelia

Cancers, Vol. 9, Iss. 5, 2017-05 ,pp. : 46-46

MDPI

Access to resources Recommend Favorite

Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4530-4537

Spandidos Publications

Access to resources Recommend Favorite

Stimulatory effects of sorafenib on human nonsmall cell lung cancer cells in vitro by regulating MAPK/ERK activation

Molecular Medicine Reports, Vol. 9, Iss. 1, 2014-01 ,pp. : 365-369

Spandidos Publications

Access to resources Recommend Favorite

Human mesenchymal stem cells enhance cancer cell proliferation via IL-6 secretion and activation of ERK1/2

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 391-397

Spandidos Publications

Access to resources Recommend Favorite

Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 372-382

Spandidos Publications

Access to resources Recommend Favorite